Health insurance coverage for children with congenital deformities, medical liability reform, IPAB (S.351/H.R.351), combatting false advertising in health care (H.R. 1427). access to breast reconstruction surgery for women with breast cancer (S.931/H.R.1984), meaningful use changes, essential health benefits, SGR/physician payment reform.
SGR/payment reform, graduate medical education (H.R.1201, H.R.1180, S.1152), private contracting for Medicare beneficiaries and their physicians (S.236/H.R.1301), electronic health records (H.R.1331), clinical data registry reporting.
Duration: February 28, 2008
to
September 30, 2014
General Issues: Health Issues , Medicare/Medicaid , Budget/Appropriations , Medical/Disease Research/Clinical Labs
Spending: about $4,022,360 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2008: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Office of Management & Budget (OMB), Federal Trade Commission (FTC),, Agency for Health Care Policy & Research, Congressional Budget Office (CBO), Food & Drug Administration (FDA), Congressional Budget Office (CBO),
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
4th Quarter, 2014
In 4A, American Society of Plastic Surgeons did no lobbying for itself. The report was filed on Sept. 23, 2015.
Original Filing: 300750261.xml
4th Quarter, 2014
In Q4, American Society of Plastic Surgeons did no lobbying for itself. The report was filed on Jan. 30, 2015.
Original Filing: 300710035.xml
3rd Quarter, 2014
American Society of Plastic Surgeons in-house lobbying effort was terminated on Nov. 23, 2015
Original Filing: 300767928.xml
Lobbying Issues
Health insurance coverage for children with congenital deformities, medical liability reform, IPAB (S.351/H.R.351), combatting false advertising in health care (H.R. 1427). access to breast reconstruction surgery for women with breast cancer (S.931/H.R.1984), meaningful use changes, essential health benefits, SGR/physician payment reform.
Agencies Lobbied
U.S. Senate
Lobbying Issues
SGR/payment reform, graduate medical education (H.R.1201, H.R.1180, S.1152), private contracting for Medicare beneficiaries and their physicians (S.236/H.R.1301), electronic health records (H.R.1331), clinical data registry reporting.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2014
In Q3, American Society of Plastic Surgeons had in-house lobbyists. The report was filed on Oct. 17, 2014.
Original Filing: 300681426.xml
Lobbying Issues
Health insurance coverage for children with congenital deformities, medical liability reform, IPAB (S.351/H.R.351), combatting false advertising in health care (H.R. 1427). access to breast reconstruction surgery for women with breast cancer (S.931/H.R.1984), meaningful use changes, essential health benefits, SGR/physician payment reform.
Agencies Lobbied
U.S. Senate
Lobbying Issues
SGR/payment reform, graduate medical education (H.R.1201, H.R.1180, S.1152), private contracting for Medicare beneficiaries and their physicians (S.236/H.R.1301), electronic health records (H.R.1331), clinical data registry reporting.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2014
In Q2, American Society of Plastic Surgeons had in-house lobbyists. The report was filed on July 22, 2014.
Original Filing: 300669973.xml
Lobbying Issues
SGR/physician payment reform, access to breadt reconstruction surgery for women women with breast cancer (S. 931/HR 1984), IPAB repeal (S. 351/HR 351), combatting false advertising in health care (HR. 1427), medical liabilty reform, electronic health records meaningful use reform (HR. 1331), health insurance coverage for children with congenital deformities
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
SGR/physician payment reform, IPAB repeal (S. 351/HR. 351), medical liability reform, electronic health records meaningful use reform (HR. 1331), private contracting for Medicare beneficiaries and their physicians (S. 236/HR. 1310), graduate medical education (S. 1152/HR. 1180/HR. 1201), clinical data registry reporting, combatting false advertising in health care (HR. 1427), insurance coverage for children with congenital deformities
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2014
In Q1, American Society of Plastic Surgeons had in-house lobbyists. The report was filed on April 17, 2014.
Original Filing: 300638357.xml
Lobbying Issues
Health insurance coverage for children with congenital deformities, medical liability reform, IPAB repeal (S. 351/H.R. 351), combatting false advertising in health care (H.R. 1427), access to breast reconstruction surgery for women with breast cancer (S. 931/H.R. 1984), electronic health records meaningful use reform (H.R. 1331), SGR/physician payment reform
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health insurance coverare for children with congenital deformities, medical liability reform, IPAB repeal (S. 351/H.R. 351), combatting false advertising in health care (H.R. 1427), electronic health records meaningful use changes (H.R. 1331), SGR/physician payments reform, graduate medical education (S. 1152, H.R. 1180, H.R. 1201), private contracting for Medicare beneficiaries and their physicians (S. 236/H.R. 1301), clinical data registry reporting
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2013
American Society of Plastic Surgeons amended a lobbying report for in-house lobbying in Q42013 on Sept. 23, 2015
Original Filing: 300750260.xml
Lobbying Issues
Health insurance coverage for children with congenital deformities, medical liability reform, IPAB (S.351/H.R.351), combating false advertising in health care (H.R.1427), access to breast reconstruction surgery for women with breast cancer (S.931/H.R.1984), meaningful use changes, essential health benefits, SGR/physician payment reform.
Agencies Lobbied
U.S. Senate
4th Quarter, 2013
In Q4, American Society of Plastic Surgeons had in-house lobbyists. The report was filed on Jan. 14, 2014.
Original Filing: 300613995.xml
Lobbying Issues
Health insurance coverage for children with congenital deformities, medical liability reform, IPAB (S. 351/H.R. 351), combatting false advertising in health care (H.R. 1427), access to breast reconstruction surgery for women with breast cancer (S. 931/H.R. 1984), meaningful use changes, essential health benefits, SGR/physician payment reform
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health insurance coverage for children with congenital deformities, medical liability reform, IPAB (S. 351/H.R. 351), combatting false advertising in health care (H.R. 1427), meaningful use changes, SGR/physician payment reform, graduate medical education (H.R. 1201, H.R. 1180, S. 1152), private contracting for Medicare beneficiaries and their physicians (S. 236/H.R. 1301), electronic health records (H.R. 1331), clinical data registry reporting
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2013
In Q3, American Society of Plastic Surgeons had in-house lobbyists. The report was filed on Oct. 1, 2013.
Original Filing: 300590254.xml
Lobbying Issues
Health insurance coverage for children with congenital deformities, medical liability reform, IPAB (S. 351/H.R. 351), combatting false advertising in healthcare (H.R. 1427), access to breast reconstruction surgery for women with breast cancer (S. 931/H.R. 1984), meaningful use changes, SGR/physician payment reform
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health insurance coverage for children with congenital deformities, medical liability reform, IPAB (S. 351/H.R. 351), combatting false advertising in health care (H.R. 1427), meaningful use changes, SGR/physician payment reform, graduate medical education (S. 1152, H.R. 1180, H.R. 1201), private contracting for Medicare beneficiaries and their physicians (S. 236/H.R. 1301), electronic health records (H.R. 1331), registry reporting
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2013
In Q2, American Society of Plastic Surgeons had in-house lobbyists. The report was filed on July 15, 2013.
Original Filing: 300572359.xml
Lobbying Issues
Health insurance coverage for children with congenital deformities, medical liability reform, IPAB (S. 351/H.R. 351), combatting false advertising in health care (H.R. 1427), access to breast reconstruction surgery for women with breast cancer (S. 931/H.R. 1984), meaningful use changes, essential health benefits, SGR/physician payment reform
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health insurance coverage for children with congenital deformities, medical liability reform, IPAB (S. 351/H.R. 351), combatting false advertising in health care (H.R. 1427), meaningful use changes, SGR/physician payment reform, graduate medical education (H.R. 1201, H.R. 1180, S. 1152), private contracting for Medicare beneficiaries and their physicians (S. 236/H.R. 1301), electronic health records (H.R. 1331), registry reporting
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2013
In Q1, American Society of Plastic Surgeons had in-house lobbyists. The report was filed on April 19, 2013.
Original Filing: 300556091.xml
Lobbying Issues
health insurance coverage for children with congenital deformities, medical liability reform, IPAB, combatting false advertising in health care, access for women to breast reconstruction information, meaningful use changes, essential health benefits, SGR/physician payment reform, fiscal cliff legislation HR 8.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Medicaid
4th Quarter, 2012
In Q4, American Society of Plastic Surgeons had in-house lobbyists. The report was filed on Jan. 23, 2013.
Original Filing: 300543335.xml
Lobbying Issues
see next pageCARES Act, H.R. 1955 and S. 1054 - providing health insurance for children with congenital and medical deformities
Medical Practice Freedom Act of 2011, H.R. 5 - to ensure medical liability reform and repeal the IPAB
Health Care Bureaucrats Elimination Act, S. 668 - IPAB repeal
The Health Care Truth and Transparency Act of 2011 - to combat false advertising
H.R. 816 - to ensure PPACA does not create new causes of action
Breast Cancer Patient Education Act, H.R. 5937 - to direct the Secretary of HHS to develop a campaign directed toward educating women on their post-cancer reconstruction options
Electronic Health Records - EHR Improvements Act
Essential Health Benefits
H.R. 6575 - to improve the RAC program
Sustainable Growth Rate (SGR) reform
H.R. 6142, which extends Medicare physician payment rates for 1 year
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Physician Payment/SGR; quality reporting and physician quality measures; ACOs, H.R. 816, the Provider Shield Act of 2011 to protect from new causes of action in PPACA; S. 668, the Health Care Bureaucrats Elimination Act to repeal IPAB; H.R. 5, HEALTH Act, to ensure medical liability reform and to repeal the IPAB, H.R. 1700 to allow physicians to privately contract, Budget Control Act; H.R. 6142, which extends Medicare physician payment rates for 1 year
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2012
In Q3, American Society of Plastic Surgeons had in-house lobbyists. The report was filed on Oct. 9, 2012.
Original Filing: 300504439.xml
Lobbying Issues
see next pageCARES Act, H.R. 1955 and S. 1054 - providing health insurance coverage for children with congenital and medical deformities
Medical Practice Freedom Act of 2011, H.R. 5 - to ensure medical liability reform and repeal IPAB
Health Care Bureaucrats Elimination Act, S. 668 - IPAB Repeal
The Health Care Truth and Transparency Act of 2011 - to combat false advertising
H.R. 816 - to ensure PPACA does not create new causes of action
Breast Cancer Patient Education Act, H.R. 5937 - to direct the Secretary of HHS to develop a campaign directed toward educating woman on their post-cancer reconstruction options
Electronic Health Records
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Physician Payment/SGR; quality reporting and physician quality measures; ACOs; H.R. 816, the Provider Shiled Act of 2011 to protect from new causes of action in PPACA; S. 668, the Health Care Bureaucrats Elimination Act to repeal IPAB; H.R. 5, HEALTH Act, to ensure medical liability reform and to repeal the IPAB; H.R. 1700 to allow physicians to privately contract, Budget Control Act
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2012
In Q2, American Society of Plastic Surgeons had in-house lobbyists. The report was filed on July 10, 2012.
Original Filing: 300481828.xml
Lobbying Issues
see next pageCARES Act, H.R. 1955 and S. 1054 - providing health insurance coverage for children with congenital medical deformities
Medical Practice Freedom Act of 2011, H.R. 969 - to ensure no health nsurance participation requirement as a condition of licensure
HEALTH Act of 2011, H.R. 5 - to ensure medical liability reform and repeal IPAB
Health Care Bureaucrats Elimination Act, S. 668 - IPAB Repeal
The Health Care Truth and Transparency Act of 2011, H.r. 451 - to combat false advertising
H.R. 816 to ensure PPACA does not create new causes of action
Keeping IDs Safe Act, H.R. 3475
Appropriations request for the Pediatric Subspecialty Loan Repayment Program
Breast Cancer Patient Education Act, H.R. 5937 - to direct the Secretary of HHS to develop a campaign directed toward educating women on their post-cancer reconstruction options
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Physician Payment/SGR; quality reporting and physician quality measures; ACOs; H.R. 816, the Provider Shield Act of 2011 to protect from new causes of action in PPACA; S. 668, the Health Care Bureaucrats Elimination Act to repeal IPAB; H.R. 5, HEALTH Act, to ensure medical liability reform and to repeal the IPAB; H.R. 1700 to allow physicians to privately contract
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2012
In Q1, American Society of Plastic Surgeons had in-house lobbyists. The report was filed on April 18, 2012.
Original Filing: 300464742.xml
Lobbying Issues
see next pageCARES Act, HR 1955 and S 1054 providing health insurance coverage for children with congenital medical deformities; HR 969 Medical Practice Freedom Act of 2011 to ensure no health insurance participation requirement as a condition of licensure; HR 5 HEALTH Act of 2011 to ensure medical liability reform and repeal IPAB, S. 668, the Health Care Bureaucrats Elimination Act (IPAB repeal), HR 451, Health Care Truth and Transparency Act of 2011 to combat false advertising; HR 816 to ensure PPACA does not create new causes of action, HR 3475, Keeping IDs Safe Act, appropriation request for Pediatric Subspecialty Loan Repayment Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Physician Payment/SGR; quality reporting and physician quality measures; ACOs; HR 816, the Provider Shield Act of 2011 to protect from new causes of action in PPACA; S. 668 Health Care Bureaucrats Elimination Act to repeal IPAB; HR 5, HEALTH Act, to ensure medical liability reform and to repeal the IPAB, HR 1700 to allow physicians to privately contract
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2011
In Q4, American Society of Plastic Surgeons had in-house lobbyists. The report was filed on Jan. 19, 2012.
Original Filing: 300443892.xml
Lobbying Issues
CARES Act -- HR 1955 & S 1054 providing health insurance coverage for children with congenital medical deformities; HR 969 Medical Practice Freedom Act of 2011 to ensure no health insurance participation requirement as a condition of licensure; HR 5 HEALTH Act of 2011 to ensure medical liability reform; HR 451, Health Care Truth and Transparency Act of 2011 to combat false advertising; HR 816 to ensure PPACA does not create new causes of action
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
physician payment/SGR; quality reporting and physician quality measures; ACOs; HR 816, the Provider Shield Act of 2011 to protect from new causes of action in PPACA; S. 668 Health Care Bureaucrats Elimination Act to repeal IPAB; HR 452 Medicare Decisions Accountability Act of 2011 to repeal IPAB; HR 1700 to allow physicians to privately contract
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2011
In Q3, American Society of Plastic Surgeons had in-house lobbyists. The report was filed on Oct. 20, 2011.
Original Filing: 300429430.xml
Lobbying Issues
CARES Act -- HR 1955 & S 1054 providing health insurance coverage for children with congenital medical deformities; HR 969 Medical Practice Freedom Act of 2011 to ensure no health insurance participation requirement as a condition of licensure; HR 5 HEALTH Act of 2011 to ensure medical liability reform; HR 451, Health Care Truth and Transparency Act of 2011 to combat false advertising; HR 816 to ensure PPACA does not create new causes of action
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
physician payment/SGR; quality reporting and physician quality measures; ACOs; HR 816, the Provider Shield Act of 2011 to protect from new causes of action in PPACA; S. 668 Health Care Bureaucrats Elimination Act to repeal IPAB; HR 452 Medicare Decisions Accountability Act of 2011 to repeal IPAB; HR 1700 to allow physicians to privately contract
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2011
In Q2, American Society of Plastic Surgeons had in-house lobbyists. The report was filed on July 20, 2011.
Original Filing: 300403796.xml
Lobbying Issues
CARES Act - introduction of HR 1955 & S 1054, providing health insurance coverage for children with congenital medical deformities; HR 969 Medical Practice Freedom Act of 2011 to ensure no health insurance participation requirement as a condition of licensure; HR 5 HEALTH Act of 2011 to ensure medical liability reform; HR 451, Healthcare Truth and Transparency Act of 2011 to combat false advertising; HR 816 to ensure PPACA does not create new causes of action
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
physician payment/SGR; quality reporting and physician quality measures; ACOs; HR 816, the Provider Shield Act of 2011 to protect from new causes of action in PPACA; S. 668 Health Care Bureaucrats Elimination Act to repeal IPAB; HR 452 Medicare Decisions Acountability Act of 2011 to repeal IPAB; HR 1700 to allow physicians to privately contract
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2011
In Q1, American Society of Plastic Surgeons had in-house lobbyists. The report was filed on April 19, 2011.
Original Filing: 300370505.xml
Lobbying Issues
Children's Access to Reconstructive Evaluation and Surgery (CARES) -- seeking reintroduction of bill providing health insurance coverage for children with congenital medical deformities; H.R. 969 Medical Practice Freedom Act of 2011 to ensure no insurance participation requirement as a condition of licensure; H.R. 5, Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011 to ensure medical liability reform; H.R. 451, Healthcare Truth and Transparency Act of 2011 to combat false advertising
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
physician payment; SGR; quality reporting and physician quality measures; ACOs; H.R. 816, the Provider Shield Act of 2011 to protect from new causes of action in PPACA; S. 668 Health Care Bureaucrats Elimination Act to repeal IPAB; H.R. 452 Medicare Decisions Accountability Act of 2011 to repeal IPAB
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2010
In Q4, American Society of Plastic Surgeons had in-house lobbyists. The report was filed on Jan. 20, 2011.
Original Filing: 300350050.xml
Lobbying Issues
H.R. 1339; S. 1235: The Children's Access to Reconstructive Evaluation and Surgery (CARES) Act -- health insurance coverage for children with congenital medical deformities; H.R. 4985, the Medicare Decisions Accountability Act of 2010 -- to repeal IPAB; S. 3653 -- Eliminate Health Care Bureaucrats Act; H.R. 5295; the Health Care Truth and Transparency Act of 2010
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare Physician Payment Issues including Sustainable Growth Rate (SGR)
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2010
In Q3, American Society of Plastic Surgeons had in-house lobbyists. The report was filed on Oct. 20, 2010.
Original Filing: 300324154.xml
Lobbying Issues
H.R. 1339; S. 1235; the Children's Access to Reconstructive Evaluation and Surgery (CARES) Act -- health insurance coverage for children with congenital medical deformities; H.R. 4985, the Medicare Decisions Accountability Act of 2010 -- to repeal IPAB; S. 3653 -- Eliminate Health Care Bureaucrats Act; H.R. 5295; the Health Care Truth and Transparency Act of 2010 -- to give FTC additional monies for combatting false advertising
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare Physician Payment Issues including SGR
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2010
In Q2, American Society of Plastic Surgeons had in-house lobbyists. The report was filed on July 20, 2010.
Original Filing: 300299332.xml
Lobbying Issues
H.R. 1339; S. 1235; the Children's Access to Reconstructive Evaluation and Surgery (CARES) Act -- health insurance coverage for children with congenital medical deformities; H.R. 4985, the Medicare Decisions Accountability Act of 2010 -- to repeal IPAB; H.R. 5295; the Health Care Truth and Transparency Act of 2010 -- to give FTC additional monies for combatting false advertising
Agencies Lobbied
U.S. Senate
Lobbying Issues
Patient Protection and Affordable Care Act (health system reform) issues including physician payment; cosmetic tax; quality measures; IPAB; HIT incentives
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2010
In Q1, American Society of Plastic Surgeons had in-house lobbyists. The report was filed on April 20, 2010.
Original Filing: 300270363.xml
Lobbying Issues
H.R. 1339; S. 1235; the Children's Access to Reconstructive Evalutation and Surgery (CARES) Act -- health insurance coverage for children with congenital medical deformities; cosmetic tax (included in Senate health reform proposal)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
HR 3962; American's Affordable Health Choices Act (Senate and House versions of health reform)
physician payment; cosmetic tax; SGR; quality reporting and physician quality measures; IMAC/IPAB; HIT incentives; physician disclosure provisions; specialty hospitals; payment methodologies; CMS innovation center; practice expense data; public plan option; medical liability reform; primary care; efficiency bonus
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2009
In Q4, American Society of Plastic Surgeons had in-house lobbyists. The report was filed on Jan. 19, 2010.
Original Filing: 300238417.xml
Lobbying Issues
H.R. 1339; S. 1235; the Children's Access to Reconstructive Evaluation and Surgery (CARES) Act -- health insurance coverage for children with congenital medical deformities; cosmetic tax (included in Senate health reform proposal)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3962; America's Affordable Health Choices Act of 2009
physician payment; cosmetic tax; health reform; SGR; separate conversion factors; quality reporting; IMAC/IPAB; HIT incentive timelines; physician disclosure provisions; specialty hospitals; innovative payment methods; CMS innovation center; practice expense data; public plan option; medical liability reform; primary care; physician quality measures; efficiency bonus
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2009
In Q3, American Society of Plastic Surgeons had in-house lobbyists. The report was filed on Oct. 19, 2009.
Original Filing: 300211042.xml
Lobbying Issues
H.R. 1339; S. 1235; the Children's Access to Reconstructive Evaluation and Surgery (CARES) Act -- health insurance coverage for children with congenital medical deformities
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H. R. 3200, America's Affordable Health Choices Act of 2009
America's Healthy Future Act -- Senate Finance Committee mark of Chairman Baucus.
Physician payment and health reform generally --SGR, separate conversion factors, quality reporting, IMAC, HIT incentive timelines, physician disclosure provisions, specialty hospitals, innovative payment methods, CMS innovation center, DME participation, practice expense data, electronic health records privacy and use of claims data, public plan option, medical liability reform, workforce and residency training issues, hospital acquired conditions, payments to primary care, PQRI and physician level quality measures, "efficiency" bonus and penalties.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2009
In Q2, American Society of Plastic Surgeons had in-house lobbyists. The report was filed on July 20, 2009.
Original Filing: 300191707.xml
Lobbying Issues
H.R. 1339; S. 1235; the Children's Access to Reconstructive Evaluation and Surgery (CARES) Act -- health insurance coverage for children with congenital medical deformities
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3200, America's Affordable Health Choices Act of 2009
Physician Payment generally -- SGR, separate conversion factors, quality reporting, HIT incentive timelines, physician disclosure provisions, specialty hospitals, innovative payment methods, DME participation, public plan option, medical liability reform, workforce and residency taining issues, hospital acquaired conditions, payments to primary care.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2009
In Q1, American Society of Plastic Surgeons had in-house lobbyists. The report was filed on April 17, 2009.
Original Filing: 300154939.xml
Agencies Lobbied
Federal Trade Commission (FTC),
Lobbying Issues
Medicare Physician Payment and Reform Issues, Medicare Quality Initiatives, Ambulatory Surgical Centers Payment
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Trauma Systems Planning Appropriations -- development of trauma care systems
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2008
In Q4, American Society of Plastic Surgeons had in-house lobbyists. The report was filed on Jan. 15, 2009.
Original Filing: 300120994.xml
Lobbying Issues
H.R. 1655 and S. 1588, the Children's Access to Reconstructive Evaluation and Surgery (CARES) Act --health insurance coverage for children with congenital medical deformities.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare Physician Payment issues, Medicare quality initiatives, ICD-10, Ambulatory Surgical Centers Payment
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2008
In Q3, American Society of Plastic Surgeons had in-house lobbyists. The report was filed on Oct. 14, 2008.
Original Filing: 300091784.xml
Lobbying Issues
H.R. 1655 and S. 1588, the Children's Access to Reconstructive Evaluation and Surgery (CARES) Act -- health insurance coverage for children with congenital medical deformities.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 6331, the Medicare Improvements for Patients and Providers Act of 2008.
Physician Quality Improvement Initiatives -- Performance Measures, HIT, ICD-10, Hospital Acquired Conditions.
DME competitive bidding (H.R. 6252 and S. 3144, Medicare DMEPOS Competitive Acquisition Reform Act of 2008) and H.R. 6331 (see above) -- specifically, negative pressure wound therapy.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2008
In Q2, American Society of Plastic Surgeons had in-house lobbyists. The report was filed on July 18, 2008.
Original Filing: 300074550.xml
Lobbying Issues
H.R. 1655 and S. 1588, the Children's Access to Reconstructive Evaluation and Surgery (CARES) Act -- health insurance coverage for children with congenital medical deformities.
Physician Quality Improvement -- Performance Measures, HIT, ICD-10
FDA Plastic Surgery Devices Panel
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 2785, the Save Medicare Act. Medicare Physician Payment Reform. Physician Performance Measures.
H.R. 6331, the Medicare Improvements for Patients and Providers Act.
DME competitive bidding issue including H.R. 6252 and S. 3144, Medicare DMEPOS Competitive Acquisition Reform Act of 2008 and H.R. 6331.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2008
American Society of Plastic Surgeons amended a lobbying report for in-house lobbying in Q12008 on March 11, 2009
Original Filing: 300140352.xml
Lobbying Issues
H.R. 1655 and S. 1588, the Children's Access to Reconstructive Evaluation and Surgery (CARES) Act -- health insurance coverage fo children with congenital medical deformities.
Medical Liability Reform
Patient Safety -- PSO Regulation (HHS Office of Civil Rights and AHRQ) Physician Quality Improvement Initiatives -- Performance Measures, HIT, ICD-10
FDA Plastic Surgery Device Panel
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 2785, the Save Medicare Act, Medicare Physician Payment Reform.
Physician Performance Measures
S. 2250 and H.R. 1823, the Ambulatory Surgical Center Medicare Payment Modernization Act -- reform of payments and access to ambulatory surgical centers.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Trauma Systems Planning -- development of trauma systems of care across U.S.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2008
American Society of Plastic Surgeons filed a lobbying registration on July 16, 2008 for in-house lobbying efforts, effective Feb. 28, 2008.
Original Filing: 300070315.xml
Issue(s) they said they’d lobby about: 1. Health insurance coverage for children with medical deformities; 2. Medicare physician payment (Congress and CMS); 3. Appropriations -- Trauma System Planning; 4. Ambulatory Surgical Centers (Congress and CMS); 5. Health insurance Reform; 6. Medicare Quality Improvement -- including health information technology, pay for performance, public reporting and ICD-10 (Congress, CMS and AHRQ); 7. Silicone Breast Implants (Congress and FDA); 8. Emergency Care; 9. Medical Liability Reform .
1st Quarter, 2008
American Society of Plastic Surgeons amended a lobbying report for in-house lobbying in Q12008 on July 17, 2008
Original Filing: 300070333.xml
Lobbying Issues
H.R. 1655 and S. 1588, the Children's Access to Reconstructive Evaluation and Surgery (CARES) Act -- health insurance coverage for children with congenital medical deformities.
Medical Liability Reform
Patient Safety -- PSO Regulation (HHS Office of Civil Rights and AHRQ)Physician Quality Improvement Initiatives -- Performance Measures, HIT, ICD-10
FDA Plastic Surgery Device Panel
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 2785, the Save Medicare Act. Medicare Physician Payment Reform.
Physician Performance Measures
S. 2250 and H.R. 1823, the Ambulatory Surgical Center Medicare Payment Modernization Act -- reform of payments and access to ambulatory surgery centers.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Trauma Systems Planning -- development of trauma systems of care across U.S.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2008
In Q1, American Society of Plastic Surgeons had in-house lobbyists. The report was filed on April 16, 2008.
Original Filing: 300045166.xml
Lobbying Issues
H.R.1655 and S.1588 , the Children's Access to Reconstructive Evaluation and Surgery (CARES) Act -- health insurance coverage for children with congenital medical deformities.
Medical Liability Reform Patient Safety -- PSO regulation (HHS Office of Civil Rights and AHRQ)
Physician Quality Improvement Initiatives -- Performance Measures, HIT, ICD-10
FDA Plastic Surgery Device Panel
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 2785, the Save Medicare Act. Medicare Physician Payment reform.
Physician Performance Measures
S. 2250 and H.R. 1823, the Ambulatory Surgical Center Medicare Payment Modernization Act -- reform of payments and access to ambulatory surgery centers.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Trauma Systems Planning -- development of trauma systems of care across US.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2008
American Society of Plastic Surgeons filed a lobbying registration on April 6, 2008 for in-house lobbying efforts, effective Feb. 28, 2008.
Original Filing: 300032915.xml
Issue(s) they said they’d lobby about: 1. Health insurance coverage for children with medical deformities; 2. Medicare physician payment (Congress and CMS); 3. Appropriations -- Trauma System Planning; 4. Ambulatory Surgical Centers (Congress and CMS); 5. Health Insurance Reform; 6. Medicare Quality Improvement -- including health information technology, pay for performance, public reporting and ICD-10 (Congress, CMS and AHRQ); 7. Silicone Breast Implants (Congress and FDA) 8. Emergency Care 9. Medical Laibility Reform .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...